Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Clinical characteristics and outcomes of cerebral venous sinus thrombosis in hematologic malignancy patients pre- and post-hematopoietic stem cell transplantation: A single-center retrospective study in China

Juanjuan Li, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Fengrong Wang, Xiang-Yu Zhao, Meng Lv, YuHong Chen, Yu Wang, Ying-jun Chang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3126.

https://doi.org/10.1182/blood-2025-3126

Published: 2025

Journal Articles

Mutational patterns and prognosis in younger versus older AML patients with myelodysplasia-related gene mutations undergoing allogeneic hematopoietic stem cell transplantation

Li-Ping Guo, Yuqian Sun, Meng Lv, Xiao-Dong Mo, Yi-Fei Cheng, Lan-Ping Xu, Xiaohui Zhang, Xiaojun Huang, Yu Wang

Blood (2025) 146 (Supplement 1): 6071.

https://doi.org/10.1182/blood-2025-6071

Published: 2025

Journal Articles

Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT

Ao-Ran Zhang, Guanhua Hu, Xianying Yin, Sheng-Ye Lu, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiangyu Zhao, Xiaojun Huang, Yi-Fei Cheng, Meng Lv

Blood (2025) 146 (Supplement 1): 4298.

https://doi.org/10.1182/blood-2025-4298

Published: 2025

Journal Articles

Low dose of IL-2 application for graft-versus-host disease prophylaxis following haploidentical stem cell transplantation

Xiangyu Zhao, Zhengli Xu, Meng Lv, Xingxing Yu, Yiyang Ding, Ting-ting Han, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Yuqian Sun, Lanping Xu, Xiaohui Zhang, Yu Wang, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 7774.

https://doi.org/10.1182/blood-2025-7774

Published: 2025

Journal Articles

Avatrombopag improves platelet engraftment after haploidentical hematopoietic stem cell transplantation: A randomized, double-blind, multicenter, placebo-controlled trial

Blood (2025) 146 (Supplement 1): 377.

https://doi.org/10.1182/blood-2025-377

Published: 2025

Journal Articles

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Blood (2025) 146 (Supplement 1): 120.

https://doi.org/10.1182/blood-2025-120

Published: 2025

Journal Articles

A novel predictive model for posttransplant lymphoproliferative disorder in the letermovir prophylaxis era

Chen-Cong Wang, Xuying Pei, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Fengrong Wang, Yuqian Sun, Meng Lv, Xiangyu Zhao, Yuhong Chen, Yu Wang, Ying-Jun Chang, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4269.

https://doi.org/10.1182/blood-2025-4269

Published: 2025

Journal Articles

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Blood (2025) 146 (Supplement 1): 4267.

https://doi.org/10.1182/blood-2025-4267

Published: 2025

Journal Articles

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with B-cell acute lymphoblastic leukemia: Insights from real-world data

Blood (2025) 146 (Supplement 1): 5122.

https://doi.org/10.1182/blood-2025-5122

Published: 2025

Journal Articles

CARMA-1: The phase I Study of SENL101, a naturally selected nanobody based CD7 CAR-T therapy, in relapsed or refractory T-ALL/lbl

Xiangyu Zhao, Wei Li Zhao, Xiaoxi Zhou, Huilai Zhang, Ting Niu, Hongsheng Zhou, Aibin Liang, Xi Zhang, Meng Lv, Lingshuang Sheng, Na Kuang, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 5931.

https://doi.org/10.1182/blood-2025-5931

Published: 2025

Journal Articles

Kte-X19 in relapsed or refractory adult B-cell acute lymphoblastic leukemia in the Chinese population: 6-month analysis of a phase II multicenter trial

Meng Lv, Hao Jiang, Yuhua Li, Yicheng Zhang, Jie Jin, Hongsheng Zhou, Kailin Xu, Mingfeng Zhao, Xin Du, Kai Hu, Jun Hu, Jinghua Zhao, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 1563.

https://doi.org/10.1182/blood-2025-1563

Published: 2025

Journal Articles

Clinical features and prognostic model for adenovirus infection following allogeneic hematopoietic stem cell transplantation: Insights from a Chinese cohort

Jiaxin Zhang, Jin Wu, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Feng-Rong Wang, Yuqian Sun, Meng Lv, Yuhong Chen, Xiang-Yu Zhao, Yu Wang, Ying-Jun Chang, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 6056.

https://doi.org/10.1182/blood-2025-6056

Published: 2025

Journal Articles

Outcomes and risk factors of second allogeneic hematopoietic stem cell transplantation in patients with relapsed hematological malignancy after first transplantation

Xiaolu Zhu, Hai-Xia Fu, Jing Liu, Zhengli Xu, Yuqian Sun, Meng Lv, Xiao-Dong Mo, Yi-Fei Cheng, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Yu Wang

Blood (2025) 146 (Supplement 1): 6047.

https://doi.org/10.1182/blood-2025-6047

Published: 2025

Journal Articles

Novel insights from the largest cohort to date: Elucidating risk factors, clinical outcomes, and prognostic predictors in autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation

Liqian Zhang, Zhuo-Yu An, Peng Zhao, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Fengrong Wang, Yuqian Sun, Meng Lv, Xiangyu Zhao, YuHong Chen, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 6046.

https://doi.org/10.1182/blood-2025-6046

Published: 2025

Journal Articles

Thrombotic thrombocytopenic purpura after allogeneic hematopoietic cell transplantation: A rare but fatal complication.

Blood (2025) 146 (Supplement 1): 6045.

https://doi.org/10.1182/blood-2025-6045

Published: 2025

Journal Articles

Comparative high-dimensional profiling reveals distinct immune reconstitution dynamics between CD19 and CD7 CAR-T therapies in acute leukemia

Xuying Pei, Zhipeng Zhou, Zhifan Zhao, Meng Lv, Xiangyu Zhao, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 4099.

https://doi.org/10.1182/blood-2025-4099

Published: 2025

Journal Articles

Next-day manufactured CD19 CAR-T cells exhibit superior persistence compared to conventional CAR-T therapy in R/R B-ALL

Meng Lv, Xu-Ying Pei, Yan-Ping Ding, Zhipeng Zhou, Luhan Deng, Zhuo-Jun Liu, Jing Liu, Leping Zhang, Qian Jiang, Xiaohui Zhang, Xin-An Lu, Xiao-Zheng Zhao, Guang-Hua Liu, Ting He, Xiaojun Huang, Xiangyu Zhao

Blood (2025) 146 (Supplement 1): 2407.

https://doi.org/10.1182/blood-2025-2407

Published: 2025

Journal Articles

Phase 1/2, multi-center, open-label clinical study to evaluate the safety, pharmacokinetics, and efficacy of zefamenib in patients with relapsed/refractory acute leukemia

Blood (2025) 146 (Supplement 1): 5209.

https://doi.org/10.1182/blood-2025-5209

Published: 2025

Journal Articles

Droplet digital PCR improves measurable residual disease detection and predicts relapse in KMT2A-rearranged leukemia after allogeneic hematopoietic stem cell transplantation: A prospective study

Ya Luo, Ya-Zhen Qin, Xiaosu Zhao, Ying-Jun Chang, Jing Liu, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Meng Lv

Blood (2025) 146 (Supplement 1): 3518.

https://doi.org/10.1182/blood-2025-3518

Published: 2025

Journal Articles

Real-world efficacy of inaticabtagene autoleucel in adult B-cell acute lymphoblastic leukemia patients with high-risk molecular alterations

Blood (2025) 146 (Supplement 1): 6865.

https://doi.org/10.1182/blood-2025-6865

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Clinical characteristics and outcomes of cerebral venous sinus thrombosis in hematologic malignancy patients pre- and post-hematopoietic stem cell transplantation: A single-center retrospective study in China

Mutational patterns and prognosis in younger versus older AML patients with myelodysplasia-related gene mutations undergoing allogeneic hematopoietic stem cell transplantation

Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT

Low dose of IL-2 application for graft-versus-host disease prophylaxis following haploidentical stem cell transplantation

Avatrombopag improves platelet engraftment after haploidentical hematopoietic stem cell transplantation: A randomized, double-blind, multicenter, placebo-controlled trial

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

A novel predictive model for posttransplant lymphoproliferative disorder in the letermovir prophylaxis era

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with B-cell acute lymphoblastic leukemia: Insights from real-world data

CARMA-1: The phase I Study of SENL101, a naturally selected nanobody based CD7 CAR-T therapy, in relapsed or refractory T-ALL/lbl

Kte-X19 in relapsed or refractory adult B-cell acute lymphoblastic leukemia in the Chinese population: 6-month analysis of a phase II multicenter trial

Clinical features and prognostic model for adenovirus infection following allogeneic hematopoietic stem cell transplantation: Insights from a Chinese cohort

Outcomes and risk factors of second allogeneic hematopoietic stem cell transplantation in patients with relapsed hematological malignancy after first transplantation

Novel insights from the largest cohort to date: Elucidating risk factors, clinical outcomes, and prognostic predictors in autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation

Thrombotic thrombocytopenic purpura after allogeneic hematopoietic cell transplantation: A rare but fatal complication.

Comparative high-dimensional profiling reveals distinct immune reconstitution dynamics between CD19 and CD7 CAR-T therapies in acute leukemia

Next-day manufactured CD19 CAR-T cells exhibit superior persistence compared to conventional CAR-T therapy in R/R B-ALL

Phase 1/2, multi-center, open-label clinical study to evaluate the safety, pharmacokinetics, and efficacy of zefamenib in patients with relapsed/refractory acute leukemia

Droplet digital PCR improves measurable residual disease detection and predicts relapse in KMT2A-rearranged leukemia after allogeneic hematopoietic stem cell transplantation: A prospective study

Real-world efficacy of inaticabtagene autoleucel in adult B-cell acute lymphoblastic leukemia patients with high-risk molecular alterations

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only